LOC390245 inhibitors constitute a specialized chemical class designed to selectively target and modulate the function of the non-coding RNA LOC390245. As a member of the extensive family of non-coding RNAs, LOC390245 is categorized as a long intergenic non-protein coding RNA (lincRNA). Despite its lack of protein-coding capacity, lincRNAs have emerged as crucial regulators of diverse cellular processes. The inhibitors developed for LOC390245 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.
The molecular architecture of LOC390245 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. In laboratory research, these inhibitors serve as essential tools, enabling scientists to probe the nuanced functions of LOC390245 in various cellular contexts. By manipulating the function of LOC390245, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC390245 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Histone deacetylase inhibitor (HDACi) that can alter chromatin structure and potentially downregulate gene expression, including KDM4E. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective HDAC inhibitor that may indirectly affect the expression of various genes by changing acetylation patterns. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter DNA methylation and gene expression patterns. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, decitabine can inhibit DNA methylation, potentially leading to reactivation of silenced genes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Can chelate metal ions and might inhibit metalloenzymes like lysine-specific demethylases, affecting their expression indirectly. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
An HDAC inhibitor that can modulate gene expression profiles and may impact KDM4E expression. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
NF-κB pathway inhibitor that could potentially downregulate genes involved in inflammation and other processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A tyrosine kinase inhibitor that may also modulate histone acetylation and methylation, thus affecting gene expression. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
An inhibitor of S-adenosylhomocysteine hydrolase which can lead to reduced methylation levels, impacting gene expression. | ||||||
AGI-6780 | 1432660-47-3 | sc-480257 | 2.5 mg | $330.00 | ||
A selective small molecule inhibitor of the CBP/p300 bromodomains, could impact transcription and gene expression. | ||||||